Evidence map›Paper›PMID 34285421›Full record

ArticleNature medicine2021

Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.

Yuanmeng Jin, Krishna Ratnam, Peter Y Chuang, Ying Fan, Yifei Zhong, Yan Dai, Amin R Mazloom, Edward Y Chen, Vivette D'Agati, Huabao Xiong and 4 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Yuanmeng Jin *Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Krishna Ratnam *Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Peter Y Chuang *Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Ying FanDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Yifei ZhongDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Yan DaiDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Amin R MazloomDepartment of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA.
Edward Y ChenDepartment of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA.
Vivette D'AgatiDepartment of Pathology, Columbia University, New York, New York, USA.
Huabao XiongImmunobiology Center, Mount Sinai School of Medicine, New York, New York, USA.
Michael J RossDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Nan ChenDepartment of Nephrology, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Avi Ma'ayanDepartment of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA. avi.maayan@mssm.edu.
John Cijiang HeDivision of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. cijiang.he@mssm.edu.
Icahn School of Medicine at Mount Sinai · USColumbia University · USRuijin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34285421
OpenAlexW3183202303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.